Nr 546 week 6 Study guides, Study notes & Summaries
Looking for the best study guides, study notes and summaries about Nr 546 week 6? On this page you'll find 104 study documents about Nr 546 week 6.
All 104 results
Sort by
-
NR 546 Week 6 Addiction Medication Table
- Other • 4 pages • 2023
- Available in package deal
-
- $9.49
- 11x sold
- + learn more
Chamberlain NR 546 Week 6 Addiction Medication Table
-
NR 546 WEEK 7 ADHD Medication Table (Updated)
- Exam (elaborations) • 3 pages • 2023 Popular
- Available in package deal
-
- $14.99
- 6x sold
- + learn more
NR 546 WEEK 7 ADHD Medication Table (Updated). Methylphenidate (D/L) 
(Concerta, Ritalin) 
-Dopamine, norepinephrine 
inhibitor and releaser 
(DNRIRe), stimulant, FDA 
approved for ADHD in 
children and adults (ages vary 
based on formulations), 
narcolepsy. Off-label for 
treatmentresistant depression. 
Enhancement DA and NE in 
certain areas of the brain 
(dorsolateral prefrontal cortex, 
medial prefrontal cortex). 
Primary target symptoms: 
concentration, attention span, 
motor hyperactivity,...
-
NR 546 Week 6 DB Case Study- Alcohol Use Disorder
- Other • 6 pages • 2023
- Available in package deal
-
- $7.99
- 3x sold
- + learn more
Chamberlain NR 546 Week 6 DB Case Study- Alcohol Use Disorder
-
NR 546 Week 6 Addiction Medications Table | Latest 2023/2024
- Exam (elaborations) • 13 pages • 2023
- Available in package deal
-
- $13.49
- 1x sold
- + learn more
NR 546 Week 6 Addiction Medications Table | Latest 2023/2024. 
Maintenance treatment of 
opioid dependence 
 Induction of treatment for 
opioid dependence 
(Bunavail only) 
Half-life: 
Buprenorphine: 
24–42 hours 
Naloxone: 
2–12 hours 
Metabolism: CYP 450 
3A4 
Notable Side Effects: 
 Headache, constipation, 
nausea 
 Oral hypoesthesia, 
glossodynia 
 Orthostatic hypotension 
 Implant specific: 
insertion site pain, 
Initial Dosing Considerations: 
 Patients must be in a m...
-
NR 546 WEEK 7 ADHD Medication Table | NR 546 Week 1-7 Quiz’s | Midterm Exam With Answers and Rationales | NR 546 Week 6 Addiction Medications Table | NR 546 Week 8 Neurotransmitter Table Chamberlain
- Package deal • 4 items • 2023
-
- $20.49
- 1x sold
- + learn more
NR 546 WEEK 7 ADHD Medication Table | NR 546 Week 1-7 Quiz’s | Midterm Exam With Answers and Rationales | NR 546 Week 6 Addiction Medications Table | NR 546 Week 8 Neurotransmitter Table Chamberlain

-
NR 546 Week 6 Case Study; Addiction (Two Versions)
- Other • 8 pages • 2022
- Available in package deal
-
- $27.49
- 6x sold
- + learn more
NR 546 Week 6 Case Study; Addiction
-
NR 546 Week 6 Case Study Addiction Chamberlain
- Other • 2 pages • 2023
- Available in package deal
-
- $15.99
- 1x sold
- + learn more
CASE STUDY 1 
HISTORY OF PRESENT ILLNESS: 
A 27-year-old male was brought to ED by his wife. He has been experiencing chest pain for 1 day starting at 2:00 a.m. He is triaged to the medical emergency department. Amedical history is taken. The client has no history of myocardial infarction (MI) orhypertension. The client is irritable and hypervigilant. He repeatedly asks the nurse if “you know what you are doing” and becomes increasingly guarded as the intern requests more details about his m...
-
NR 546 Week 7 ADHD Medication Table Latest.
- Other • 12 pages • 2023
- Available in package deal
-
- $12.99
- 3x sold
- + learn more
NR 546 Week 7 ADHD Medication Table Latest. 
Drug Name 
(include if IR, XR, 
ODT, LA) 
 
Indication (include 
approved ages) 
Neurotransmitter(s) 
Affected 
Target Symptoms 
Short-acting, 
intermediate-acting or 
long-acting. 
Duration of action, peak (if 
noted) 
Notable side effects /Patient education instructions 
Methylphenidate 
(D/L) 
(Concerta, Ritalin) 
Indication (include 
approved ages) 
Attention deficit 
hyperactivity disorder 
(ADHD) in children and 
adults (approved ages vary 
base...
-
NR 546 Week 7 ADHD Medication Table Latest.
- Other • 12 pages • 2023
- Available in package deal
-
- $11.99
- 1x sold
- + learn more
NR 546 Week 7 ADHD Medication Table Latest. 
Drug Name 
(include if IR, XR, 
ODT, LA) 
 
Indication (include 
approved ages) 
Neurotransmitter(s) 
Affected 
Target Symptoms 
Short-acting, 
intermediate-acting or 
long-acting. 
Duration of action, peak (if 
noted) 
Notable side effects /Patient education instructions 
Methylphenidate 
(D/L) 
(Concerta, Ritalin) 
Indication (include 
approved ages) 
Attention deficit 
hyperactivity disorder 
(ADHD) in children and 
adults (approved ages vary 
base...
-
NR 546 Week 6 Case Study 2023/2024 | 100% Correct Verified
- Case • 7 pages • 2023
- Available in package deal
-
- $10.49
- + learn more
NR 546 Week 6 Case Study 2023/2024 | 100% Correct Verified 
 
NR 546 Week 6 Case Study 2023/2024 | 100% Correct Verified